|
GNL2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.58232999999397E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.767400E-04 |
| Normal-vs-Stage2 |
2.858800E-01 |
| Normal-vs-Stage3 |
2.142300E-03 |
| Normal-vs-Stage4 |
7.558500E-02 |
| Stage1-vs-Stage2 |
3.593600E-01 |
| Stage1-vs-Stage3 |
1.949200E-01 |
| Stage1-vs-Stage4 |
2.660400E-01 |
| Stage2-vs-Stage3 |
1.210020E-01 |
| Stage2-vs-Stage4 |
1.705810E-01 |
| Stage3-vs-Stage4 |
5.063800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.05219999999318E-06 |
| Normal-vs-AfricanAmerican |
1.761970E-02 |
| Normal-vs-Asian |
1.899040E-01 |
| Caucasian-vs-AfricanAmerican |
2.037200E-01 |
| Caucasian-vs-Asian |
5.707000E-01 |
| AfricanAmerican-vs-Asian |
2.847400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.044700E-04 |
| Normal-vs-Female |
1.66420000002887E-06 |
| Male-vs-Female |
5.339500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.120400E-03 |
| Normal-vs-Extreme_Weight |
2.238800E-04 |
| Normal-vs-Obese |
6.969600E-04 |
| Normal-vs-Extreme_Obese |
8.569600E-02 |
| Normal_Weight-vs-Extreme_Weight |
6.166200E-01 |
| Normal_Weight-vs-Obese |
6.439800E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.907000E-01 |
| Extreme_Weight-vs-Obese |
9.762200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.951800E-01 |
| Obese-vs-Extreme_Obese |
9.833800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.191900E-04 |
| Normal-vs-Age(41-60Yrs) |
1.23709999999555E-06 |
| Normal-vs-Age(61-80Yrs) |
3.924200E-03 |
| Normal-vs-Age(81-100Yrs) |
6.100000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.405410E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.256240E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.399900E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.180300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.591500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.270200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.76888999999791E-05 |
| Normal-VS-Type2 PRCC |
8.089700E-02 |
| Normal-VS-KIRP CIMP |
6.72189999995076E-07 |
| Normal-VS-Unclassified PRCC |
1.168000E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.660800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.901560E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
7.676400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.594500E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
5.141800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.361700E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.115800E-02 |
| Normal-vs-N1 |
2.192400E-04 |
| Normal-vs-N2 |
1.720590E-01 |
| N0-vs-N1 |
4.124100E-03 |
| N0-vs-N2 |
4.387800E-02 |
| N1-vs-N2 |
9.626800E-01 |
|
|
